Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05656794
PHASE2
Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
Sponsor: University Health Network, Toronto
View on ClinicalTrials.gov
Summary
This is a prospective, randomized phase II trial investigating if radiation treatment delivered every other day for 2 weeks has the same side effects as radiation treatment delivered once weekly for 6 weeks.
Official title: Consolidative Prostate Radiotherapy in Patients With Metastatic Prostate Cancer
Key Details
Gender
MALE
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2023-08-09
Completion Date
2031-08
Last Updated
2026-03-23
Healthy Volunteers
No
Conditions
Interventions
RADIATION
Radiotherapy
Standard of care radiotherapy administered as per institutional guidelines.
Locations (1)
University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada